Hyderabad, Mar 26: Dr Reddy’s Laboratories Limited on Monday announced that it has launched
'Palonosetron Hydrochloride' Injection, 0 point 25 mg (base)/ 5 mL, a
therapeutic equivalent generic version of ALOXI® (palonosetron hydrochloride)
Injection approved by the US Food and Drug Administration (USFDA).
The ALOXI® brand and generic had U.S. sales of approximately
$446 million MAT for the most recent twelve months ending in January 2018
according to IMS Health*.
Dr. Reddy’s Palonosetron Hydrochloride Injection is available in a strength of 0.25 mg/5 mL (free base) in a single-dose vial packaged in a carton containing one vial.
ALOXI® is a registered trademark of Helsinn Healthcare SA, a statement here said. UNI
Dr. Reddy’s Palonosetron Hydrochloride Injection is available in a strength of 0.25 mg/5 mL (free base) in a single-dose vial packaged in a carton containing one vial.
ALOXI® is a registered trademark of Helsinn Healthcare SA, a statement here said. UNI
Post A Comment:
0 comments so far,add yours